ASPHALION´S COVID-19 EXPERTISE: 15 PROJECTS IN 15 MONTHS

Since the onset of the COVID-19 pandemic ASPHALION has shown its commitment towards the fight against the virus. So far, during these past 15 months we have worked in 15 COVID-19 related projects.

Since the onset of the COVID-19 pandemic ASPHALION has shown its commitment towards the fight against the virus. So far, during these past 15 months we have worked in 15 COVID-19 related projects.
June 21, 2021

Since the onset of the COVID-19 pandemic ASPHALION has shown its commitment towards the fight against the virus. So far, during these past 15 months we have worked in 15 COVID-19 related projects.

We have also contributed to the development of 3 vaccines to fight COVID-19, providing Regulatory support in terms of IMPD, IB preparation and CTA, as well as for the development of a COVID-19 vaccine and a preventive one against SARS-CoV2.

ASPHALION has also collaborated in several projects related to the treatment of COVID-19 symptoms, as well as provided Pharmacovigilance Support during clinical trials.

Regarding Medical Devices, ASPHALION has collaborated in the classification of a software as Medical Device for the follow-up of COVID-19 patients. With regard to EU-funded projects, we have been Regulatory Partner in a project called VASCOVID, which aim is to develop a portable, non-invasive and real- time health monitoring platform for the evaluation of microvascular health in COVID-19 patients that are in intensive care units.

We are proud of each one of them and look forward to keep collaborating in the fight against the pandemic, because our team´s mission is our passion: working together with our clients in order to generate ideas and implement solutions that contribute to improving health in all our lives is an essential part of our company. Because of this, at the onset of the pandemic we offered support free of charge to show our commitment towards the fight against COVID-19.

We dream about being a global reference and driving force into the evolution of the healthcare sector, offering the best environment for the individual and collective growth of our team and clients.

See Asphalion´s contributions to the fight against COVID-19 in more detail here:

COVID-19: Asphalion: 15 projects in 15 months

For further information you can contact us at: [email protected]

 

 

Search News & Events

  • Filter by category

Share

Related news and events

EVENT | WORLD DRUG SAFETY CONGRESS EUROPE 2024

The World Drug Safety Congress offers the perfect setting to address how to drive pharmacovigilance operations forward for industry professionals, international regulatory bodies and academic representatives.

NEWS | Important Update from the FDA!

This guidance recommends steps manufacturers and applicants of active pharmaceutical ingredients (APIs) and drug products should take to detect and prevent unacceptable levels of nitrosamine impurities in drug products. The guidance also describes conditions that may introduce nitrosamine impurities. The unexpected finding of nitrosamine impurities, which are probable or possible human carcinogens, in certain drug products has made clear the need for a risk assessment strategy for the potential presence of nitrosamines in any drug product.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting